Mark A. Eckert
Reproducibility track record
1
assessed papers
10/100
mean reproducibility
0
reproduced (C1–C2)
1
flagged
100
total citations
flag rate:
100%
(1/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Agnieszka Chryplewicz 1Ernst Lengyel 1Allen Zhu 1Rohit Kulkarni 1Decheng Ren 1Dario F. De Jesus 1Chuan He 1Qi Zhang 1Zijie Zhang 1Mengjie Chen 1
Institutions
Howard Hughes Medical Institute 1University of Chicago 1Joslin Diabetes Center 1Harvard University 1
Geography (author institutions)
US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (78)
Request a reproduction →1 assessed by us (0 reproduced) · 77 not yet assessed — every PubMed paper on record, linked below.
-
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types ↗Cancer Research Communications · 2025 · PMID 40981433not yet assessed
-
Abstract 3757: Development of potent orally bioavailable inhibitors of nicotinamide N-methyl transferase ↗Cancer Research · 2025not yet assessed
-
LB1255 Novel inhibitors of the scaffolding function of BTK selectively and potently block BTK signaling and are efficacious in preclinical models of chronic spontaneous urticaria ↗Journal of Investigative Dermatology · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Deep Visual Proteomics defines single-cell identity and heterogeneity ↗Nature Biotechnology · 2022 · PMID 35590073not yet assessed
-
The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment ↗Cancers · 2021 · PMID 34201616not yet assessed
-
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas ↗Gynecologic Oncology · 2021 · PMID 34452747not yet assessed
-
Isolation of Normal and Cancer-Associated Fibroblasts ↗Methods in molecular biology · 2021 · PMID 34918293not yet assessed
-
Microfluidic devices for stem cell analysis ↗Elsevier eBooks · 2021not yet assessed
-
Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas ↗Gynecologic Oncology · 2021not yet assessed
-
Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer ↗Gynecologic Oncology · 2021not yet assessed
-
not yet assessed
-
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts ↗Nature · 2019 · PMID 31043742not yet assessed
-
RADAR: differential analysis of MeRIP-seq data with a random effect model⚑Genome biology · 2019 · PMID 31870409L1 10/100 ⚑
-
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference ↗Cancer · 2019 · PMID 30835824not yet assessed
-
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6 ↗Scientific Reports · 2019 · PMID 30914657not yet assessed
-
Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation ↗Proceedings of the National Academy of Sciences · 2019 · PMID 31591248not yet assessed
-
Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis ↗The FASEB Journal · 2019not yet assessed
-
RADAR: Differential analysis of MeRIP-seq data with a random effect model ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
Individuelle Funktionalisierung von Bauteilen*/Individual functionalization of components – Digital printing processes for the electrical and sensoric functionalization of complex-shaped components ↗wt Werkstattstechnik online · 2019not yet assessed
-
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer ↗Nature Cell Biology · 2018 · PMID 30154548not yet assessed
-
Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis.Max Planck Digital Library · 2018not yet assessed
-
Abstract IA06: Stromal regulation of metastasis ↗Clinical Cancer Research · 2018not yet assessed
-
Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment.Max Planck Digital Library · 2018not yet assessed
-
Who are the long-term survivors of high grade serous ovarian cancer? ↗Gynecologic Oncology · 2017 · PMID 29128106not yet assessed
-
ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions ↗Journal of Cell Science · 2017 · PMID 28468988not yet assessed
-
An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells ↗Nature Communications · 2017 · PMID 29176560not yet assessed
-
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention ↗Cancer Prevention Research · 2017 · PMID 28264838not yet assessed
-
Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION ↗Clinical Cancer Research · 2017not yet assessed
-
Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts ↗Cancer Research · 2017not yet assessed
-
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status ↗Nature Communications · 2016 · PMID 27561551not yet assessed
-
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube ↗Cancer Discovery · 2016 · PMID 27856443not yet assessed
-
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer ↗Oncotarget · 2015 · PMID 26172303not yet assessed
-
Facile Supermolecular Aptamer Inhibitors of L-Selectin ↗PLoS ONE · 2015 · PMID 25826688not yet assessed
-
Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke ↗Neurology · 2014 · PMID 24610327not yet assessed
-
DNA‐Scaffolded Multivalent Ligands to Modulate Cell Function ↗ChemBioChem · 2014 · PMID 24803415not yet assessed
-
Cover Picture: DNA‐Scaffolded Multivalent Ligands to Modulate Cell Function (ChemBioChem 9/2014) ↗ChemBioChem · 2014not yet assessed
-
A polyvalent aptamer system for targeted drug delivery ↗Biomaterials · 2013 · PMID 24044994not yet assessed
-
Evidence for High Translational Potential of Mesenchymal Stromal Cell Therapy to Improve Recovery from Ischemic Stroke ↗Journal of Cerebral Blood Flow & Metabolism · 2013 · PMID 23756689not yet assessed
-
From Blood to the Brain: Can Systemically Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? ↗Stem Cells International · 2013 · PMID 23997771not yet assessed
-
Novel Molecular and Nanosensors for In Vivo Sensing ↗Theranostics · 2013 · PMID 23946824not yet assessed
-
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells ↗Oncotarget · 2013 · PMID 23744479not yet assessed
-
Opening windows on new biology and disease mechanisms: development of real-time in vivo sensors ↗Interface Focus · 2013not yet assessed
-
Microfluidic devices for stem cell analysis ↗Elsevier eBooks · 2013not yet assessed
-
Abstract WMP37: Methodological Quality and Meta-Analysis of Animal Studies of Mesenchymal Stromal Cells for Ischemic Stroke ↗Stroke · 2013not yet assessed
-
To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells. - eScholarship2013not yet assessed
-
The Role of Twist1 in Promoting Tumor Invasion and Metastasis by Regulation of Invadopodia FormationeScholarship (California Digital Library) · 2012not yet assessed
-
Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis ↗Cancer Cell · 2011 · PMID 21397860not yet assessed
-
Targeting invadopodia to block breast cancer metastasis ↗Oncotarget · 2011 · PMID 21725138not yet assessed
-
Abstract 4747: Twist1-induced invadopodia formation promotes tumor metastasis ↗Cancer Research · 2011not yet assessed
-
not yet assessed
-
Profiles of Clients in Government-Funded Drug User Treatment Settings ↗Substance Use & Misuse · 1996 · PMID 8851812not yet assessed
-
Critical Periods of Sensitivity of Sexually Dimorphic Spinal Nuclei to Prenatal Testosterone Exposure in Female Rats ↗Hormones and Behavior · 1996 · PMID 9047266not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Eckert M” paper on PubMed ↗